Adherence of Emergency Physicians to clinical guidelines for hyperglycemia using a specific computing tool (GLIKAL©)
DOI:
https://doi.org/10.19230/jonnpr.2016.1.1.931Keywords:
Hyperglycemia, diabetes mellitus, Emergency Department, computing tool, GLIKALAbstract
Goal: to evaluate the adherence of Emergency Physicians to clinical guidelines for medical treatment in in-hospital patients, evaluated by using a specific computing tool (GLIKAL©) in patients with hyperglycemia and/or diabetes mellitus.
Methodology: An observational study with descriptive cases was designed, with no intervention, including patients from an urban, tertiary university hospital.
Patients pending admittance were recruited, starting at the very first hours of the day, any day of the week. Inclusion criteria were age above 18 years old, with glycaemia >150 mg/dl upon admittance to hospital (with a known diabetes or not) who were admitted to hospital from the Emergency Department. The study period included was from June to October 2012. The independent variables were age, sex, previous treatment for diabetes, type of diet prescribed upon admittance, corticosteroid treatment, serum creatinine and glycaemia upon admittance to the Emergency Department. The outcome variable was the treatment suggested by the software program, which was evaluated with 11 items gathered by the specific computing tool (GLIKAL©).
Results: 125 patients were gathered, amongst which eight were discarded due to mistakes in the initial data collected. Of the remaining 117 patients, the mean age was of 78.1 years old, with 61% males. Among these 117 patients, 74 of them (63.4%) were
being treated with oral antidiabetic drugs alone or in combination with insulin, of which 13 cases (17.5%) continued having it prescribed by the physician even when it was not suitable, while no mistake was detected in the treatment specified by GLIKAL© (p<0.001). The following percentages of correct prescriptions by the physicians were found: basal insulin treatment adjusted to weight (22.6%), basal treatment adjusted to nil per os diet (0%), treatment adjusted according to newly prescribed treatment with corticosteroids (10%), adjusted to deteriorated kidney function (14.2%) or if the corrective treatment was adjusted to weight (17.9%), in comparison with 100% accomplished by GLIKAL©.
The investigators concluded that of the 117 analyzed patients, the treatment suggested by GLIKAL© was correct in all of them, as opposed to 17 (14.52%) of the treatments suggested by the physician, which constitutes a 85.4% of incorrect treatments, with 4
patients in which the treatment was considered “unclear”.
Conclusion: the adherence of the physicians from the Emergency Department to the guidelines for treating patients with
hyperglycemia or diabetes mellitus, as gathered in the GLIKAL© program, was inadequate.
Downloads
References
Carreño MC S.J, Fernández A, Bustamante A, Garcia I, Guillén A. Manejo del paciente diabético hospitalizado.
An Med Interna 2005;22:339-48.
S. Alcalde López, M. Oliete Blanco,L. Usieto López,MA. Javierre Loris,P. Parrilla Herránz,J. Povar Marco.
Intervención educativa para implantar un protocolo de tratamiento de la hiperglucemia en urgencias.
Emergencias 2013;25:43-6.
Pérez Pérez A, Conthe Gutiérrez P, Aguilar Diosdado M, Bertomeu Martínez V, Galdos Anuncibay P, García De
Casasola G, Gomis De Bárbara R, Palma Gamiz JL, Puig Domingo M, Sánchez Rodríguez A. Tratamiento de la
hiperglucemia en el hospital. Medicina Clínica 2009;132:465-75.
Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med
:449-61.
Corbett SJ. NICE recommendations for the management of hyperglycaemia in acute coronary syndrome. Heart
;98:1189-91.
Bilotta F, Rosa G. Glycemia management in critical care patients. World J Diabetes 2012;3:130-4.
Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM. Persistent poststroke hyperglycemia is
independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-14.
Laird E. A, Coates V. Systematic review of randomized controlled trials to regulate glycaemia after stroke. J Adv
Nurs 2012:263-77.
SEMES DIABETES. Protocolo para el manejo del paciente con diabetes mellitus en urgencias. 2012:1-4.
http://www.semesdiabetes.es/protocolo_diabetes_2.pdf. Último acceso 25/5/2016.
GRUPO SEMES DIABETES. Manejo del paciente diabético en urgencias.
http://wwwsemesdiabeteses/protocolo_diabetes_2pdf 2013. Último acceso 25/5/2016.
Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes
Care 2004;27:553-97.
Browning LA, Dumo P. Sliding-scale insulin: an antiquated approach to glycemic control in hospitalized patients.
Am J Health Syst Pharm 2004;61:1611-14.
Shimizu T, Nathan D. M,Buse J. B,Davidson M. B, Ferrannini E,Holman R. R, Sherwin R, Zinman, B.
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of
therapy. Nihon Rinsho 2012;70 Suppl 3:591-601.
Saigi I, Pérez A. Manejo de la hiperglucemia inducida por corticoides. Rev Clin Esp 2010;210:397–403.
Slinin Y, Ishani A, Rector T,Fitzgerald P,Macdonald R, Tacklind J, Rutks I, Wilt T. J. Management of
Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a
KDOQI Clinical Practice Guideline. Am J Kidney Dis. 2012 Nov;60(5):747-69. doi: 10.1053/j.ajkd.2012.07.017.
R. D. Cebul, T. E. Love, A. K. Jain, C. J. Hebert. Electronic Health Records and Quality of Diabetes Care. N Engl
J Med 2011:825-33.
GRUPO SEMES DIABETES. GLIKAL© 2.0: Comparación de resultados en parámetros de glucemia de una
herramienta informática validada frente a la práctica clínica habitual. http://wwwsemesdiabeteses/GLIKAL©html
Último acceso 17/7/2015.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
